MedTrace Logo

The "Light for the Brain" Study

NCT02677987 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2022-04-18

Study results available
· View outcomes & findings →

Summary

Cognitive impairment (such as memory problems) due to cancer and its treatment can interfere with quality of life and can linger long after treatment has ended, yet research examining cognitive rehabilitation approaches has produced limited clinical benefit. The proposed study will provide information about systematic light exposure for the treatment of cognitive impairment in hematopoietic stem cell transplant (HSCT) survivors and will investigate how it works. This study would facilitate the development of this potential treatment, giving health care providers and cancer survivors a much-needed tool to help with cancer-related cognitive impairment.

Conditions

  • Hematopoietic Stem Cell Transplantation
  • Cognitive Impairments
  • Sleep
  • Depression
  • Fatigue
  • Quality of Life

Interventions

DEVICE

Intervention systematic light exposure

Bright light using Litebook device.

DEVICE

Comparison systematic light exposure

Dim light using modified Litebook device.

Sponsors & Collaborators

Principal Investigators

  • Lisa M Wu, PhD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-10-31
Completion
2021-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02677987 on ClinicalTrials.gov